2009
T1155 Constipation in Children Receiving Chemotherapy for Cancer: Prevalence, Risk Factors and Severity of the Problem
Season H, Pashankar F, Beardsley D, McNamara J, Pashankar D. T1155 Constipation in Children Receiving Chemotherapy for Cancer: Prevalence, Risk Factors and Severity of the Problem. Gastroenterology 2009, 136: a-511. DOI: 10.1016/s0016-5085(09)62354-4.Peer-Reviewed Original Research
2005
224 Increased Prevalence of Obesity in Children with Functional Constipation with and Without Fecal Incontinence
Loening-Baucke V, Pashankar D. 224 Increased Prevalence of Obesity in Children with Functional Constipation with and Without Fecal Incontinence. Pediatric Research 2005, 58: 392-392. DOI: 10.1203/00006450-200508000-00253.Peer-Reviewed Original ResearchFecal incontinencePrevalence of obesityYears of ageMorbid obesityFunctional constipationMorbid obeseWell-child visitsRates of obesityObesity clinicConstipated childrenChildren's HospitalMean agePediatric clinicChild visitsHigh prevalenceConstipationIncontinenceHormonal influencesObesityControl groupPrevalenceActivity levelsGender ratioControl boysObese
2004
Polyethylene Glycol 3350 Without Electrolytes for the Treatment of Functional Constipation in Infants and Toddlers
Loening‐Baucke V, Krishna R, Pashankar D. Polyethylene Glycol 3350 Without Electrolytes for the Treatment of Functional Constipation in Infants and Toddlers. Journal Of Pediatric Gastroenterology And Nutrition 2004, 39: 536-539. DOI: 10.1002/j.1536-4801.2004.tb00904.x.Peer-Reviewed Original ResearchTreatment of functional constipationTreatment of constipationFollow-upFunctional constipationPEG therapyLong-term follow-upShort-term follow-upSafety of PEGDuration of constipationRetrospective chart reviewBody weight/dAdverse effectsLong-term dosingPolyethylene glycol 3350Chart reviewDaily treatmentAverage doseHealthy childrenPhysical examinationNo subjectConstipationDosePEG dosesMonthsShort-termPharmacotherapy of constipation in children
Pashankar D, Tolia V. Pharmacotherapy of constipation in children. Journal Of Clinical Practice 2004, 1: 149-157. DOI: 10.2217/14750708.1.1.149.Peer-Reviewed Original ResearchLong-term maintenance therapyNew prokinetic agentThird of childrenHealth care providersFecal disimpactionFunctional constipationChildhood constipationMaintenance therapyProkinetic agentsNew laxativeConstipationObvious causeTeam approachLaxativesLong-term problemsBehavioral modificationChildrenEncopresisTreatmentCommon problemDisimpactionPharmacotherapyTherapyLactuloseP0474 POLYETHYLENE GLYCOL WITHOUT ELECTROLYTES FOR THE TREATMENT OF CONSTIPATION IN INFANTS AND TODDLERS
Loening‐Baucke V, Pashankar D, Krishna R, Comstock J. P0474 POLYETHYLENE GLYCOL WITHOUT ELECTROLYTES FOR THE TREATMENT OF CONSTIPATION IN INFANTS AND TODDLERS. Journal Of Pediatric Gastroenterology And Nutrition 2004, 39: s236-s237. DOI: 10.1002/j.1536-4801.2004.tb12904.x.Peer-Reviewed Original ResearchP0474 POLYETHYLENE GLYCOL WITHOUT ELECTROLYTES FOR THE TREATMENT OF CONSTIPATION IN INFANTS AND TODDLERS
Loening-Baucke V, Pashankar D, Krishna R, Comstock J. P0474 POLYETHYLENE GLYCOL WITHOUT ELECTROLYTES FOR THE TREATMENT OF CONSTIPATION IN INFANTS AND TODDLERS. Journal Of Pediatric Gastroenterology And Nutrition 2004, 39: s236-s237. DOI: 10.1097/00005176-200406001-00598.Peer-Reviewed Original Research
2003
A randomized prospective comparison study of polyethylene glycol without electrolytes and milk of magnesia for children with constipation and encopresis
Loening-Baucke V, Pashankar D. A randomized prospective comparison study of polyethylene glycol without electrolytes and milk of magnesia for children with constipation and encopresis. Gastroenterology 2003, 124: a222. DOI: 10.1016/s0016-5085(03)81117-4.Peer-Reviewed Original Research
2001
Efficacy and optimal dose of daily polyethylene glycol 3350 for treatment of constipation and encopresis in children
Pashankar D, Bishop W. Efficacy and optimal dose of daily polyethylene glycol 3350 for treatment of constipation and encopresis in children. The Journal Of Pediatrics 2001, 139: 428-432. PMID: 11562624, DOI: 10.1067/mpd.2001.117002.Peer-Reviewed Original ResearchConceptsChronic constipationStool frequencyStool consistencyOptimal dosePolyethylene glycol 3350Weekly stool frequencyTreatment of constipationMean effective doseFisher's exact testSignificant adverse effectsStudent's t-testFecal retentionSoft stoolDaily administrationInitial doseMean doseConstipationExact testEffective doseDoseAdverse effectsT-testChildrenTreatmentEfficacy